Aliza Murtaza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aliza Murtaza has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Agnieszka Jaworowska
School of Science, Faculty of Engineering and Science, University of Greenwich, Central Avenue, Chatham ME4 4TB, UK
2 shared publications - Joshua Siaw Boateng
University of Greenwich
1 shared publication
Latest Publications
- Open Access
- 30 March 2026
- Published by MDPI AG in Sustainability
- Vol. 18 (7) , 3332
Dried Seaweeds Available in the United Kingdom Market Are a Potential Source of n-3 Polyunsaturated Fatty Acids
To address the increasing global demand for eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), novel and sustainable sources are required. Seaweeds have been identified as promising alternative sources of these fatty acids (FAs). This study evaluated the FA profiles of dry, commercially available seaweeds in the United Kingdom, including Porphyra spp., Palmaria palmata, Himanthalia elongata, Laminaria digitata, Saccharina japonica, Undaria pinnatifida, Sargassum fusiforme and Fucus vesiculosus. FA identification was performed by gas chromatography. The highest content of polyunsaturated FAs (PUFAs) was observed in U. pinnatifida, accounting for 67.68% of the total FAs (TFAs). EPA represented 33.34% of TFA content in Rhodophyta and 7.13% in Ochrophyta. EPA was the dominant FA in Porphyra spp., comprising 38.91% of TFAs (1064.40 mg/100 g dry weight). A higher content of EPA was also found in P. palmata (32.18%), L. digitata (13.76%), and U. pinnatifida (13.00%). DHA content was consistently lower than that of EPA, with the highest proportion observed in P. palmata (0.27% of TFAs). U. pinnatifida, P. palmata and Porphyra spp. appear to be the most promising seaweed species for providing n-3 long-chain PUFAs in human diets.
- 30 March 2026
- Published by MDPI AG in Sustainability
- Vol. 18 (7) , 3332
Open AccessDried Seaweeds Available in the United Kingdom Market Are a Potential Source of n-3 Polyunsaturated Fatty Acids
To address the increasing global demand for eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), novel and sustainable sources are required. Seaweeds have been identified as promising alternative sources of these fatty acids (FAs). This study evaluated the FA profiles of dry, commercially available seaweeds in the United Kingdom, including Porphyra spp., Palmaria palmata, Himanthalia elongata, Laminaria digitata, Saccharina japonica, Undaria pinnatifida, Sargassum fusiforme and Fucus vesiculosus. FA identification was performed by gas chromatography. The highest content of polyunsaturated FAs (PUFAs) was observed in U. pinnatifida, accounting for 67.68% of the total FAs (TFAs). EPA represented 33.34% of TFA content in Rhodophyta and 7.13% in Ochrophyta. EPA was the dominant FA in Porphyra spp., comprising 38.91% of TFAs (1064.40 mg/100 g dry weight). A higher content of EPA was also found in P. palmata (32.18%), L. digitata (13.76%), and U. pinnatifida (13.00%). DHA content was consistently lower than that of EPA, with the highest proportion observed in P. palmata (0.27% of TFAs). U. pinnatifida, P. palmata and Porphyra spp. appear to be the most promising seaweed species for providing n-3 long-chain PUFAs in human diets.
- Open Access
- 30 December 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 20 (1) , 730
Seaweed Derived Lipids Are a Potential Anti-Inflammatory Agent: A Review
Chronic, low-grade inflammation is linked to the development of non-communicable diseases, including cancer, cardiovascular disease, obesity, insulin resistance, diabetes, and others which together contribute to more than 50% of deaths globally. Modulation of inflammatory responses may be a promising strategy, and n-3 long chain polyunsaturated fatty acids (n-3 LC-PUFA) may offer a new therapeutic option in inflammatory conditions. Seaweeds are characterised by high nutritional quality and are a good source of many bioactive compounds, including n-3 LC-PUFA. This review addresses the potential anti-inflammatory properties of seaweed derived lipids, and their immunomodulating mechanisms in order to identify the possible applications of seaweed as an anti-inflammatory functional food ingredient or dietary supplement. A few studies have evaluated the anti-inflammatory activity of seaweed lipids using crude lipid extracts, lipid fractions and isolated complex lipids from several seaweeds belonging to the Ochrophyta and Rhodophyta phyla, with only three Ulva rigida, Ulva sp. and Codium tomentosum within the Chlorophyta phylum. It was reported that seaweed derived lipids suppress inducible nitric oxide synthase and cyclooxygenase-2 expression and reduce nuclear factor κB p100 and myeloid differentiation primary response 88 protein levels leading to the downregulation of the production of several pro-inflammatory cytokines and nitric oxide. Further investigations are required to unravel the complex mechanisms underlying their preventive action against chronic inflammation and their potential use as a new functional food ingredient and/or health supplement.
- 30 December 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 20 (1) , 730
Open AccessSeaweed Derived Lipids Are a Potential Anti-Inflammatory Agent: A Review
Chronic, low-grade inflammation is linked to the development of non-communicable diseases, including cancer, cardiovascular disease, obesity, insulin resistance, diabetes, and others which together contribute to more than 50% of deaths globally. Modulation of inflammatory responses may be a promising strategy, and n-3 long chain polyunsaturated fatty acids (n-3 LC-PUFA) may offer a new therapeutic option in inflammatory conditions. Seaweeds are characterised by high nutritional quality and are a good source of many bioactive compounds, including n-3 LC-PUFA. This review addresses the potential anti-inflammatory properties of seaweed derived lipids, and their immunomodulating mechanisms in order to identify the possible applications of seaweed as an anti-inflammatory functional food ingredient or dietary supplement. A few studies have evaluated the anti-inflammatory activity of seaweed lipids using crude lipid extracts, lipid fractions and isolated complex lipids from several seaweeds belonging to the Ochrophyta and Rhodophyta phyla, with only three Ulva rigida, Ulva sp. and Codium tomentosum within the Chlorophyta phylum. It was reported that seaweed derived lipids suppress inducible nitric oxide synthase and cyclooxygenase-2 expression and reduce nuclear factor κB p100 and myeloid differentiation primary response 88 protein levels leading to the downregulation of the production of several pro-inflammatory cytokines and nitric oxide. Further investigations are required to unravel the complex mechanisms underlying their preventive action against chronic inflammation and their potential use as a new functional food ingredient and/or health supplement.